[1]Chenard;Bordner;Butler;Chambers;Collins;DeCosta;Ducat;Dumont;Fox;Mena;Menniti;Nielsen;Pagnozzi;Richter;Ronau;Shalaby;Stemple;White[JournalofMedicinalChemistry,1995,vol.38,#16,p.3138-3145]
[1]Chenard;Bordner;Butler;Chambers;Collins;DeCosta;Ducat;Dumont;Fox;Mena;Menniti;Nielsen;Pagnozzi;Richter;Ronau;Shalaby;Stemple;White[JournalofMedicinalChemistry,1995,vol.38,#16,p.3138-3145]
[1]Chenard;Bordner;Butler;Chambers;Collins;DeCosta;Ducat;Dumont;Fox;Mena;Menniti;Nielsen;Pagnozzi;Richter;Ronau;Shalaby;Stemple;White[JournalofMedicinalChemistry,1995,vol.38,#16,p.3138-3145]
[1]Chenard;Bordner;Butler;Chambers;Collins;DeCosta;Ducat;Dumont;Fox;Mena;Menniti;Nielsen;Pagnozzi;Richter;Ronau;Shalaby;Stemple;White[JournalofMedicinalChemistry,1995,vol.38,#16,p.3138-3145]
[1]Chenard;Bordner;Butler;Chambers;Collins;DeCosta;Ducat;Dumont;Fox;Mena;Menniti;Nielsen;Pagnozzi;Richter;Ronau;Shalaby;Stemple;White[JournalofMedicinalChemistry,1995,vol.38,#16,p.3138-3145]
Title: MK-801, but not naloxone, attenuates high-dose dextromethorphan-induced convulsive behavior: Possible involvement of the GluN2B receptor.
Journal: Toxicology and applied pharmacology 20171101
Title: Traxoprodil decreases pentylenetetrazol-induced seizures.
Journal: Epilepsy research 20120601
Title: Effects of NMDA receptor antagonists with different subtype selectivities on retinal spreading depression.
Journal: British journal of pharmacology 20120101
Title: Behavioral deficits and cellular damage following developmental ethanol exposure in rats are attenuated by CP-101,606, an NMDAR antagonist with unique NR2B specificity.
Journal: Pharmacology, biochemistry, and behavior 20120101
Title: A complex interaction between glycine/NMDA receptors and serotonergic/noradrenergic antidepressants in the forced swim test in mice.
Journal: Journal of neural transmission (Vienna, Austria : 1996) 20111101
Title: A role for glutamate in subjective response to smoking and its action on inhibitory control.
Journal: Psychopharmacology 20110701
Title: Nonselective and NR2B-selective N-methyl-D-aspartic acid receptor antagonists produce antinociception and long-term relief of allodynia in acute and neuropathic pain.
Journal: Anesthesiology 20110701
Title: 2,6-Disubstituted pyrazines and related analogs as NR2B site antagonists of the NMDA receptor with anti-depressant activity.
Journal: Bioorganic & medicinal chemistry letters 20110601
Title: The effects of NMDA receptor antagonists on attentional set-shifting task performance in mice.
Journal: Psychopharmacology 20110401
Title: Triheteromeric NR1/NR2A/NR2B receptors constitute the major N-methyl-D-aspartate receptor population in adult hippocampal synapses.
Journal: The Journal of biological chemistry 20110304
Title: Involvement of spinal NR2B-containing NMDA receptors in oxaliplatin-induced mechanical allodynia in rats.
Journal: Molecular pain 20110101
Title: Lack of efficacy of NMDA receptor-NR2B selective antagonists in the R6/2 model of Huntington disease.
Journal: Experimental neurology 20101001
Title: Forelimb dyskinesia mediated by high-frequency stimulation of the subthalamic nucleus is linked to rapid activation of the NR2B subunit of N-methyl-D-aspartate receptors.
Journal: The European journal of neuroscience 20100801
Title: Innovative approaches to treatment - refractory depression: The ketamine story.
Journal: Indian journal of psychiatry 20100101
Title: Glutamate-based antidepressants: 20 years on.
Journal: Trends in pharmacological sciences 20091101
Title: Comments on 'An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606 in patients with treatment-refractory major depressive disorder'.
Journal: Journal of clinical psychopharmacology 20090801
Title: An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder.
Journal: Journal of clinical psychopharmacology 20081201
Title: Effects of a NR2B selective NMDA glutamate antagonist, CP-101,606, on dyskinesia and Parkinsonism.
Journal: Movement disorders : official journal of the Movement Disorder Society 20081015
Title: Amygdala infusions of an NR2B-selective or an NR2A-preferring NMDA receptor antagonist differentially influence fear conditioning and expression in the fear-potentiated startle test.
Journal: Learning & memory (Cold Spring Harbor, N.Y.) 20080201
Title: The phencyclidine-like discriminative stimulus effects and reinforcing properties of the NR2B-selective N-methyl-D-aspartate antagonist CP-101 606 in rats and rhesus monkeys.
Journal: Behavioural pharmacology 20071201
Title: Discovery of (-)-6-[2-[4-(3-fluorophenyl)-4-hydroxy-1-piperidinyl]-1-hydroxyethyl]-3,4-dihydro-2(1H)-quinolinone--a potent NR2B-selective N-methyl D-aspartate (NMDA) antagonist for the treatment of pain.
Journal: Bioorganic & medicinal chemistry letters 20071015
Title: Metabolism, distribution and excretion of a selective N-methyl-D-aspartate receptor antagonist, traxoprodil, in rats and dogs.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20070801
Title: Nitric oxide (NO) serves as a retrograde messenger to activate neuronal NO synthase in the spinal cord via NMDA receptors.
Journal: Nitric oxide : biology and chemistry 20070801
Title: Effects of pan- and subtype-selective N-methyl-D-aspartate receptor antagonists on cortical spreading depression in the rat: therapeutic potential for migraine.
Journal: The Journal of pharmacology and experimental therapeutics 20070501
Title: Selective NR1/2B N-methyl-D-aspartate receptor antagonists among indole-2-carboxamides and benzimidazole-2-carboxamides.
Journal: Journal of medicinal chemistry 20070308
Title: Arthritis and pain. Future targets to control osteoarthritis pain.
Journal: Arthritis research & therapy 20070101
Title: NR2B subunit exerts a critical role in postischemic synaptic plasticity.
Journal: Stroke 20060701
Title: Glutamate-based therapeutic approaches: NR2B receptor antagonists.
Journal: Current opinion in pharmacology 20060201
Title: Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
Journal: Clinical pharmacokinetics 20060101
Title: The effect of the selective NMDA receptor antagonist traxoprodil in the treatment of traumatic brain injury.
Journal: Journal of neurotrauma 20051201
Title: Fyn kinase-mediated phosphorylation of NMDA receptor NR2B subunit at Tyr1472 is essential for maintenance of neuropathic pain.
Journal: The European journal of neuroscience 20050901
Title: Lack of NMDA receptor subtype selectivity for hippocampal long-term potentiation.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20050720
Title: Evidence for improved performance in cognitive tasks following selective NR2B NMDA receptor antagonist pre-treatment in the rat.
Journal: Psychopharmacology 20050401
Title: NMDA/NR2B selective antagonists in the treatment of ischemic brain injury.
Journal: Current drug targets. CNS and neurological disorders 20050401
Title: Brain but not spinal NR2B receptor is responsible for the anti-allodynic effect of an NR2B subunit-selective antagonist CP-101,606 in a rat chronic constriction injury model.
Journal: Pharmacology 20050101
Title: Characterization of N-methyl-D-aspartate receptor subunits responsible for postoperative pain.
Journal: European journal of pharmacology 20041025
Title: Oxamides as novel NR2B selective NMDA receptor antagonists.
Journal: Bioorganic & medicinal chemistry letters 20040802
Title: NR2B selective NMDA receptor antagonist CP-101,606 prevents levodopa-induced motor response alterations in hemi-parkinsonian rats.
Journal: Neuropharmacology 20040801
Title: The NR2B-selective NMDA receptor antagonist CP-101,606 exacerbates L-DOPA-induced dyskinesia and provides mild potentiation of anti-parkinsonian effects of L-DOPA in the MPTP-lesioned marmoset model of Parkinson's disease.
Journal: Experimental neurology 20040801
Title: Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol.
Journal: Brain research 20040611
Title: Synthesis of 11C-labelled bis(phenylalkyl)amines and their in vitro and in vivo binding properties in rodent and monkey brains.
Journal: Biological & pharmaceutical bulletin 20040401
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20040401
Title: The NMDA receptor NR2B subunit: a valid therapeutic target for multiple CNS pathologies.
Journal: Current medicinal chemistry 20040201
Title: Characterization of N-methyl-D-aspartate receptor subunits involved in acute ammonia toxicity.
Journal: Neurochemistry international 20040101
Title: The NMDA NR2B subunit-selective receptor antagonist, CP-101,606, enhances the functional recovery the NMDA NR2B subunit-selective receptor and reduces brain damage after cortical compression-induced brain ischemia.
Journal: Journal of neurotrauma 20040101
Title: Antioxidant-accelerated oxidative degradation: a case study of transition metal ion catalyzed oxidation in formulation.
Journal: Pharmaceutical development and technology 20040101
Title: The effect of (+/-)-CP-101,606, an NMDA receptor NR2B subunit selective antagonist, in the Morris watermaze.
Journal: European journal of pharmacology 20030829
Title: 2-(3,4-Dihydro-1H-isoquinolin-2yl)-pyridines as a novel class of NR1/2B subtype selective NMDA receptor antagonists.
Journal: Bioorganic & medicinal chemistry letters 20030310
Title: Novel N1-(benzyl)cinnamamidine derived NR2B subtype-selective NMDA receptor antagonists.
Journal: Bioorganic & medicinal chemistry letters 20030224
Title: Reduced brain infarct volume and improved neurological outcome by inhibition of the NR2B subunit of NMDA receptors by using CP101,606-27 alone and in combination with rt-PA in a thromboembolic stroke model in rats.
Journal: Journal of neurosurgery 20030201
Title: Differential alterations in the expression of NMDA receptor subunits following chronic ethanol treatment in primary cultures of rat cortical and hippocampal neurones.
Journal: Neurochemistry international 20030101
Title: Metabolism, pharmacokinetics, and excretion of a highly selective N-methyl-D-aspartate receptor antagonist, traxoprodil, in human cytochrome P450 2D6 extensive and poor metabolizers.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20030101
Title: Synthesis, in vitro and in vivo pharmacology of a C-11 labeled analog of CP-101,606, (+/-)threo-1-(4-hydroxyphenyl)-2-[4-hydroxy-4-(p-[11C]methoxyphenyl)piperidino]-1-propanol, as a PET tracer for NR2B subunit-containing NMDA receptors.
Journal: Nuclear medicine and biology 20020701
Title: Studies on the subtype selectivity of CP-101,606: evidence for two classes of NR2B-selective NMDA receptor antagonists.
Journal: Neuropharmacology 20020301
Title: Prevention of cocaine-induced convulsions and lethality in mice: effectiveness of targeting different sites on the NMDA receptor complex.
Journal: Neuropharmacology 20000128
Title: Chenard BL, et al. (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: a potent new neuroprotectant which blocks N-methyl-D-aspartate responses. J Med Chem. 1995 Aug 4;38(16):3138-45.
Title: Poleszak E, et al. Traxoprodil, a selective antagonist of the NR2B subunit of the NMDA receptor, potentiates the antidepressant-like effects of certain antidepressant drugs in the forced swim test in mice. Metab Brain Dis. 2016 Aug;31(4):803-14.
Title: Naspolini AP, et al. Traxoprodil decreases pentylenetetrazol-induced seizures. Epilepsy Res. 2012 Jun;100(1-2):12-9.
